Evidence map›Paper›PMID 38904011›Full record

ArticleInternational journal of biological sciences2024

Particulate matter facilitates amphiregulin-dependent lung cancer proliferation through glutamine metabolism.

Ya-Jing Jiang, Trung-Loc Ho, Chia-Chia Chao, Xiu-Yuan He, Po-Chun Chen, Fang-Ju Cheng, Wei-Chien Huang, Chang-Lun Huang, Po-I Liu, Chih-Hsin Tang

Abstract read
In one paragraph

Article in International journal of biological sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Amphiregulin in Fibrotic Diseases and Cancer.International journal of molecular sciences · 2025
    Review
  7. Targeting glutamine metabolism as a potential target for cancer treatment.Journal of experimental & clinical cancer research : CR · 2025
    Review
  8. Article
  9. Joint exposure to PMFrontiers in public health · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ya-Jing JiangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Trung-Loc HoGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Chia-Chia ChaoDepartment of Respiratory Therapy, Fu-Jen Catholic University, New Taipei City, Taiwan.
Xiu-Yuan HeGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Po-Chun ChenDepartment of Life Science, National Taiwan Normal University, Taipei, Taiwan.
Fang-Ju ChengGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Wei-Chien HuangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Chang-Lun HuangDivision of General Thoracic Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan.
Po-I LiuDepartment of Physical Therapy, Asia University, Taichung, Taiwan.
Chih-Hsin TangGraduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although many cohort studies have reported that long-term exposure to particulate matter (PM) causes lung cancer, the molecular mechanisms underlying the PM-induced increases in lung cancer progression remain unclear. We applied the lung cancer cell line A549 (Parental; A549.Par) to PM for an extended period to establish a mimic PM-exposed lung cancer cell line, A549.PM. Our results indicate that A549.PM exhibits higher cell growth and proliferation abilities compared to A549.Par cells

Indexed as

AmphiregulinGlutamineLung NeoplasmsParticulate MatterA549 CellsAmino Acid Transport System ASCAnimalsCell Line, TumorCell ProliferationHumansMiceMinor Histocompatibility AntigensSignal TransductionTOR Serine-Threonine KinasesAmino Acid Transport System ASCAmphiregulinAREG protein, humanGlutamineMinor Histocompatibility AntigensParticulate MatterSLC1A5 protein, humanTOR Serine-Threonine KinasesAmphiregulinGlutamine metabolismLung cancerParticulate matterSLC1A5

Identifiers

PMID38904011
PMCPMC11186359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.